Stocks That Fell to 3-Year Lows in the Week of July 28

Macerich Co., Dr. Reddy's Laboratories Ltd., Foot Locker Inc. and Seneca Foods Corp

Author's Avatar
Jul 30, 2017
Article's Main Image

Macerich Co (MAC, Financial), Dr. Reddy's Laboratories Ltd (RDY, Financial), Foot Locker Inc (FL, Financial), and Seneca Foods Corp (SENEB, Financial) have declined to their three-year lows.

Macerich Co (MAC, Financial) Declined to $57.85

The prices of Macerich Co (MAC, Financial) shares have declined to $57.85 on July 28, which is only 3.1% above the 3-year low of $56.06.

Macerich Co is an American self-managed real estate investment trust. It is the third-largest owner and operator of shopping centers in the United States, operating as a S&P 500 component. The company owns property across the United States, including property in California, Arizona, Washington, Missouri, and New York.

Macerich Co has a market cap of $8.2 billion; its shares were traded around $57.85 with a P/E ratio of 50.29 and P/S ratio of 8.10. The trailing 12-month dividend yield of Macerich Co stocks is 4.85%. The forward dividend yield of Macerich Co stocks is 4.64%. Macerich Co had an annual average earnings growth of 2.30% over the past 10 years.

On April 27 Macerich Co announced financial results for the first quarter 2017. The company reported a net income of $69.2 million or $0.48 per diluted share for the first quarter 2017 compared to net income of $420.9 million or $2.67 per diluted share for the first quarter 2016. The company also reported $133.6 million from funds from diluted operations for the quarter compared to $141 for the first quarter 2016.

Dr. Reddy's Laboratories Ltd (RDY, Financial) Declined to $36.79

The prices of Dr. Reddy's Laboratories Ltd (RDY, Financial) shares have declined to $36.79 on July 28, which is the new three year low.

Dr. Reddy's Laboratories Ltd is an Indian international pharmaceutical company based in Hyderabad, India. The company manufactures and markets a variety of pharmaceuticals, including over 190 medications and 60 active pharmaceutical ingredients, both in India and internationally. The company’s primary products include diagnostic kits, critical care, and biotechnology products.

Dr. Reddy's Laboratories Ltd has a market cap of $6.47 billion; its shares were traded around $36.79 with a P/E ratio of 32.19 and P/S ratio of 2.78. The trailing 12-month dividend yield of Dr. Reddy's Laboratories Ltd stocks is 0.79%. Dr. Reddy's Laboratories Ltd had an annual average earnings growth of 22.80% over the past 10 years.

On July 27 Dr. Reddy's Laboratories Ltd announced first quarter 2018 financial results. The company reported consolidated revenues of 33.2 billion rupees, a year over year growth of 3%. The company also reported gross profit margins of 51.6%, a decline of around 460 basis points compared to last year. The company had a profit after tax of .6 billion rupees, which is 1.8% of total revenues.

Foot Locker Inc (FL, Financial) Declined to $46.02

The prices of Foot Locker Inc (FL, Financial) shares have declined to $46.02 on July 28, which is only 3.1% above the 3-year low of $44.59.

Foot Locker Inc is an American international sportswear and footwear retailer, operating in 28 countries. The company operates the Foot Locker chain of athletic footwear retail outlets and other athletic based divisions including Champs Sports and House of Hoops. The company has 3,363 stores as of Jan. 28, 2017, most of which are mall-based.

Foot Locker Inc has a market cap of $6.04 billion; its shares were traded around $46.02 with a P/E ratio of 9.43 and P/S ratio of 0.79. The trailing 12-month dividend yield of Foot Locker Inc stocks is 2.54%. The forward dividend yield of Foot Locker Inc stocks is 2.62%. Foot Locker Inc had an annual average earnings growth of 26.60% over the past 10 years.

On May 19 Foot Locker Inc announced first quarter 2017 results. The company reported a net income of $180 million, or $1.36 per share, compared with net income of $191 million, or $1.39 per share in the same period of 2016. The first quarter comparable-store sales increased 0.5%, while total sales increased 0.7% from the same period last year to $2.001 billion this year.

Seneca Foods Corp (SENEB, Financial) Declined to $30.90

The prices of Seneca Foods Corp (SENEB, Financial) shares have declined to $30.90 on July 28, which is only 4.5% above the 3-year low of $29.50.

Seneca Foods Corp is an American food processor and distributor that primarily produces canned, frozen, and bottled produce under private label as well as national and regional brands that the company owns or licenses. The company also produces products under the Green Giant and Le Sueur labels per an agreement with General Mills.

Seneca Foods Corp has a market cap of $289.520 million; its shares were traded around $30.90 with a P/E ratio of 22.43 and P/S ratio of 0.23. Seneca Foods Corp had an annual average earnings growth of 6.10% over the past 5 years.

On May 25 Seneca Foods Corp announced financial results for the fourth quarter and year ended march 31, 2017. The company reported a net sales decrease of 2.3% to $1.246 billion, which is attributed to unfavorable sales mix and lower selling price. Furthermore, the company reported net earnings of $12.6 million, or $1.27 per diluted share, compared to $54.5 million, or $5.42 per diluted share during the same quarter the previous year.

Disclosure: I do not own stock in any of the companies mentioned in the article.